Encouraging developments included an opportunity to build on the blockbuster debut of GSK’s RSV vaccine and the potential return of a previously withdrawn cancer drug.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,